BlueBrainBoost
freedom-pharmacy
Purchases through the above links give commission which helps fund this website
Recent literature: Vasopressin receptor 1A antagonist
Date Journal Article title
2018 J Thorac Cardiovasc Surg Enhanced coronary arteriolar contraction to vasopressin in patients with diabetes after cardiac surgery.
2018 Neuropeptides Selective and non-selective OT receptor agonists induce different locomotor behaviors in male rats via central OT receptors and peripheral V1a receptors.
2018 Peptides Vasopressin V1a receptors are present in the carotid body and contribute to the control of breathing in male Sprague-Dawley rats.
2018 Korean J Physiol Pharmacol Oxytocin produces thermal analgesia via vasopressin-1a receptor by modulating TRPV1 and potassium conductance in the dorsal root ganglion neurons.
2018 Psychopharmacology (Berl) Differential activation of arginine-vasopressin receptor types in the amygdaloid modulation of anxiety in the rat by arginine-vasopressin.
2018 Eur J Pain The role of peripheral vasopressin 1A and oxytocin receptors on the cutaneous vasopressin antinociceptive effects.
2017 Neuropsychopharmacology A Single Dose, Randomized, Controlled Proof-Of-Mechanism Study of a Novel Vasopressin 1a Receptor Antagonist (RG7713) in High-Functioning Adults with Autism Spectrum Disorder.
2018 Genes Brain Behav Genetic variation in the developmental regulation of cortical avpr1a among prairie voles.
2017 Pain Oxytocin alleviates orofacial mechanical hypersensitivity associated with infraorbital nerve injury through vasopressin-1A receptors of the rat trigeminal ganglia.
2016 Brain Res Bull Regional c-Fos expression induced by peripheral oxytocin administration is prevented by the vasopressin 1A receptor antagonist SR49059.
2016 Nov Neurosci Lett Activation of arginine vasopressin receptor 1a facilitates the induction of long-term potentiation in the accessory olfactory bulb of male mice.
2017 Neuropsychopharmacology A Single Dose, Randomized, Controlled Proof-Of-Mechanism Study of a Novel Vasopressin 1a Receptor Antagonist (RG7713) in High-Functioning Adults with Autism Spectrum Disorder.
2016 Sep Org Biomol Chem Selenazolidine: a selenium containing proline surrogate in peptide science.
2016 Sep J Physiol Role of enteroendocrine L-cells in arginine vasopressin-mediated inhibition of colonic anion secretion.
2016 Psychoneuroendocrinology Septal oxytocin administration impairs peer affiliation via V1a receptors in female meadow voles.
2016 Jan Eur J Med Chem Flexible analogues of WAY-267,464: Synthesis and pharmacology at the human oxytocin and vasopressin 1a receptors.
2015 J Cardiovasc Pharmacol Effects of Long-term Blockade of Vasopressin Receptor Types 1a and 2 on Cardiac and Renal Damage in a Rat Model of Hypertensive Heart Failure.
2015 Psychoneuroendocrinology Endogenous vasopressin, innate anxiety, and the emission of pro-social 50-kHz ultrasonic vocalizations during social play behavior in juvenile rats.
2015 Apr Neurosci Lett Spinal vasopressin alleviates formalin-induced nociception by enhancing GABAA receptor function in mice.
2015 Psychopharmacology (Berl) WAY 267,464, a non-peptide oxytocin receptor agonist, impairs social recognition memory in rats through a vasopressin 1A receptor antagonist action.
2015 Mar J Med Chem Discovery of highly selective brain-penetrant vasopressin 1a antagonists for the potential treatment of autism via a chemogenomic and scaffold hopping approach.
2015 Mar Eur J Pharmacol Vasopressin-induced mouse urethral contraction is modulated by caveolin-1.
2015 Diabetologia Vasopressin and hydration play a major role in the development of glucose intolerance and hepatic steatosis in obese rats.
2015 J Endocrinol Effects of atosiban on stress-related neuroendocrine factors.
2010 Probe Reports from the NI... Optimization and characterization of an antagonist for vasopressin 1a (V1a) receptor
2014 J Physiol Pharmacol Proopiomelanocortin but not vasopressin or renin-angiotensin system induces resuscitative effects of central 5-HT1A activation in haemorrhagic shock in rats.
2014 Nov Circulation β-adrenergic receptor-mediated cardiac contractility is inhibited via vasopressin type 1A-receptor-dependent signaling.
2014 Oct Am J Physiol Regul Integr... Angiotensin II induces membrane trafficking of natively expressed transient receptor potential vanilloid type 4 channels in hypothalamic 4B cells.
2014 Sep Brain Res Selective vasopressin-1a receptor antagonist prevents brain edema, reduces astrocytic cell swelling and GFAP, V1aR and AQP4 expression after focal traumatic brain injury.
2014 Jul Neuroscience Neuroanatomical distribution of oxytocin and vasopressin 1a receptors in the socially monogamous coppery titi monkey (Callicebus cupreus).
2014 J Cereb Blood Flow Metab Water deprivation induces neurovascular and cognitive dysfunction through vasopressin-induced oxidative stress.
2014 J Pharmacol Sci Therapeutic potential of vasopressin-receptor antagonists in heart failure.
2014 Pharmacol Biochem Behav Oxytocinergic regulation of endogenous as well as drug-induced mood.
2013 Psychoneuroendocrinology Sex-specific modulation of juvenile social play by vasopressin.
2013 Pain Neurohormonal effects of oxytocin and vasopressin receptor agonists on spinal pain processing in male rats.
2013 Neuropsychopharmacology Acute prosocial effects of oxytocin and vasopressin when given alone or in combination with 3,4-methylenedioxymethamphetamine in rats: involvement of the V1A receptor.
2013 May Am J Physiol Regul Integr... Hypertension in mice with transgenic activation of the brain renin-angiotensin system is vasopressin dependent.
2013 J Pharm Sci Pharmacokinetics and metabolism of SRX246: a potent and selective vasopressin 1a antagonist.
2013 J Am Soc Hypertens Age-dependent regulation of renal vasopressin V(1A) and V₂ receptors in rats with genetic hypertension: implications for the treatment of hypertension.
2013 Feb Brain Res Predator odor-evoked BOLD activation in the awake rat: modulation by oxytocin and V₁a vasopressin receptor antagonists.
2013 Acta Neurochir (Wien) The role of vasopressin V1A receptors in cytotoxic brain edema formation following brain injury.
2012 J Pediatr Pharmacol Ther Initial experience with conivaptan use in critically ill infants with cardiac disease.
2012 Oct J Med Chem Selective fluorescent nonpeptidic antagonists for vasopressin V₂ GPCR: application to ligand screening and oligomerization assays.
2012 Circ Heart Fail Tolvaptan improves left ventricular dysfunction after myocardial infarction in rats.
2012 Sep Neuroscience Effects of arginine vasopressin on firing activity and thermosensitivity of rat POAH area neurons.
2012 PLoS One Gestational valproate alters BOLD activation in response to complex social and primary sensory stimuli.
2012 J Neuroendocrinol The nonpeptide oxytocin receptor agonist WAY 267,464: receptor-binding profile, prosocial effects and distribution of c-Fos expression in adolescent rats.
2012 J Neuroendocrinol Oxytocin and vasopressin agonists and antagonists as research tools and potential therapeutics.
2012 Chem Biol Drug Des Highly potent antidiuretic antagonists: conformational studies of vasopressin analogues modified with 1-naphthylalanine enantiomers at position 2.
2012 Mar Eur J Pharmacol Distinct receptor types mediate arginine vasopressin-dependent ACTH release and intracellular calcium mobilization in rat pituitary cells.
2012 Feb Brain Res Proconvulsive effects of oxytocin in the generalized pentylenetetrazol mouse model are mediated by vasopressin 1a receptors.
2012 Feb Regul Pept Dexamethasone stimulates the expression of ghrelin and its receptor in rat hypothalamic 4B cells.
2012 Stroke Vasopressin V(1a) receptors mediate posthemorrhagic systemic hypertension thereby determining rebleeding rate and outcome after experimental arachnoid hemorrhage.
2011 Nov Eur J Pharmacol In vitro and in vivo pharmacological characterisation of the potent and selective vasopressin V(1A) receptor antagonist 4-[4-(4-Chloro-phenyl)-5-[1,2,3]triazol-2-ylmethyl-4H-[1,2,4]triazol-3-yl]-piperidin-1-yl-(3,5-difluoro-phenyl) methanone (PF-00738245).
2012 J Psychopharmacol Modulation of anxiety behavior in the elevated plus maze using peptidic oxytocin and vasopressin receptor ligands in the rat.
2011 Oct Eur J Pharmacol Nicotine's central cardiovascular actions: receptor types involved and their possible physiological role in anaesthetized rats.
2011 Aug Bioorg Med Chem Lett Optimisation of pharmacokinetic properties to afford an orally bioavailable and selective V1A receptor antagonist.
2011 Expert Opin Pharmacother Tolvaptan for the treatment of heart failure: a review of the literature.
2011 Horm Behav Vasotocin neurons and septal V1a-like receptors potently modulate songbird flocking and responses to novelty.
2011 Neurochem Int Arginine-vasopressin V1a receptor inhibition improves neurologic outcomes following an intracerebral hemorrhagic brain injury.
2011 J Physiol Sci Vasopressin regulates rat mesangial cell growth by inducing autocrine secretion of vascular endothelial growth factor.
2011 Neuropeptides Vasopressin induces human mesangial cell growth via induction of vascular endothelial growth factor secretion.
2011 Reprod Biomed Online Oxytocin and vasopressin V(1A) receptors as new therapeutic targets in assisted reproduction.
2011 Nephron Physiol Selective blockade of oxytocin and vasopressin V(1a) receptors in anaesthetised rats: evidence that activation of oxytocin receptors rather than V(1a) receptors increases sodium excretion.
2010 Crit Care Role of selective V2-receptor-antagonism in septic shock: a randomized, controlled, experimental study.
2011 Curr Heart Fail Rep Targeting hyponatremia and hemodynamics in acute decompensated heart failure: is there a role for vasopressin antagonists?
2010 Dec Neuroscience Oxytocin and vasopressin in the medial amygdala differentially modulate approach and avoidance behavior toward illness-related social odor.
2011 Jan Gen Comp Endocrinol Identification and characterization of mesotocin and V1a-like vasotocin receptors in a urodele amphibian, Taricha granulosa.
2010 Front Horm Res Ghrelin and anterior pituitary function.
2010 Eur J Med Chem Influence of bulky 3,3'-diphenylalanine enantiomers replacing position 2 of AVP analogues on their conformations: NMR and molecular modeling studies.
2010 Jun J Neurosci Oxytocin-induced analgesia and scratching are mediated by the vasopressin-1A receptor in the mouse.
2010 Jun Bioorg Med Chem Lett Synthesis and evaluation of azabicyclo[3.2.1]octane derivatives as potent mixed vasopressin antagonists.
2010 Mar Bioorg Med Chem Lett Identification of a urea bioisostere of a triazole oxytocin antagonist.
2010 Feb J Physiol Increased vasopressin transmission from the paraventricular nucleus to the rostral medulla augments cardiorespiratory outflow in chronic intermittent hypoxia-conditioned rats.
2009 Kidney Int Vasopressin in chronic kidney disease: an elephant in the room?